SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+7.91%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
+$262M
(+39%)
Cap. Flow
+$56.6M
Cap. Flow
% of AUM
21.61%
Top 10 Holdings %
Top 10 Hldgs %
65.28%
Holding
27
New
9
Increased
11
Reduced
6
Closed
1
Top Buys
| 1 |
Insmed
INSM
|
$16.4M |
| 2 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$14.6M |
| 3 |
Viatris
VTRS
|
$9.83M |
| 4 |
Medtronic
MDT
|
$9.38M |
| 5 |
GSK
GSK
|
$8.62M |
Top Sells
| 1 |
AbbVie
ABBV
|
$9.26M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$8.11M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.49M |
| 4 |
Biogen
BIIB
|
$5.57M |
| 5 |
Orthofix Medical
OFIX
|
$3.92M |
Sector Composition
| 1 | Healthcare | 81.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Travere Therapeutics
TVTX
$1.56B
| $1.86M | 0.71% |
+158,100
| New | +$1.86M |
|
|
27
Biogen
BIIB
$19.4B
| – | – |
-18,200
| Closed | -$5.57M |
|